Saturday, October 3, 2026

USD/EUR Bearish Momentum With A 3% Slide In The Last 21 Sessions

ViaNews Editorial Team

November 27, 2023

USD/EUR Bearish Momentum With A 3% Slide In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 3.86% for the last 21 sessions. At 22:13 EST on Sunday, 26 November, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 3.022% up from its 52-week low and 5.959% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 0.10%, and a positive 0.33%, respectively.

USD/EUR's highest amplitude of average volatility was 0.34% (last week), 0.36% (last month), and 0.33% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • According to FXStreet on Friday, 24 November, "A sustained strength beyond the latter will negate any near-term negative bias and lift the USD/JPY pair to the 151.00 mark. ", "A convincing break below could drag the USD/JPY pair to the 148.35-148.30 region en route to the 148.00 round figure. "
  • Usd/jpy likely to remain almost entirely dependent on the dollar in the coming weeks – commerzbank. According to FXStreet on Friday, 24 November, "However, no one from the Japanese Ministry of Finance then needs to argue that a move in USD/JPY is fundamentally unjustified."
  • Usd/jpy price analysis: steady poised for potential uptrend as the week closes. According to FXStreet on Friday, 24 November, "The USD/JPY is almost flat late in the North American session, though set to end the week near today's opening price and exchange hands at 149.47, printing minuscule losses of 0.02%.", "The USD/JPY daily chart shows back-to-back session posting doji's, which implies traders are undecided. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com